ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
분자 모델링 시장의 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 16.0%로 170억 7,000만 달러로 성장할 전망입니다. 예측기간의 성장은 AI와 머신러닝 알고리즘의 통합, 신약 개발 요구 증가, 재료 과학에서의 응용 확대, 정밀의료와 맞춤형 치료 접근법, 가상 스크리닝에서의 이용 확대 등에 기인할 것으로 전망됩니다. 예측기간의 주요 동향에는 계산 능력의 진보, AI와 머신러닝의 통합, 신약 개발의 성장, 재료 과학 응용의 확대, 예측의료에 대한 주력 등이 포함됩니다.
향후 5년간의 예측 성장률 16.0%는 과거 예측에서 0.1% 소폭 감소한 수치입니다. 이러한 성장세 둔화는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 프랑스와 캐나다에서 개발된 양자 컴퓨팅 클라우드 플랫폼과 인공지능(AI) 기반 단백질 폴딩 소프트웨어의 가격을 증가시켜 미국의 신약 개발에 지장을 초래하여 치료법의 개발이 지연되고 계산 생물학의 지출이 증가할 가능성이 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 예상됩니다.
분자 모델링 시장은 의약품 개발의 추세가 높아지면서 성장세를 유지하고 있습니다. 의약품 개발에는 새로운 의약 화합물의 발견, 설계, 시험, 시장 출시 등의 복잡한 프로세스가 포함됩니다. 분자 모델링은 분자간 상호작용의 이해, 단백질-리간드 복합체의 안정성 평가, 기능적 신뢰성 확보, 약효 평가 등을 지원하며, 이 과정에서 매우 중요한 역할을 하고 있습니다. 캐나다의 접근성 표준 보고에 따르면 2022년에 임상시험이 실시된 신약은 약 9,000개 품목으로 전년의 약 8,500개 품목에서 크게 증가하였습니다. 이러한 의약품 개발 활동의 급증은 분자 모델링 시장 성장의 중요한 기폭제가 되고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 분자 모델링 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 분자 모델링 시장 : 성장률 분석
세계의 분자 모델링 시장 실적 : 규모와 성장(2019-2024년)
세계의 분자 모델링 시장 예측 : 규모와 성장(2024-2029년, 2034F)
세계의 분자 모델링 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 분자 모델링 시장 : 제품별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
소프트웨어
서비스
세계의 분자 모델링 시장 : 접근법별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
분자역학 접근
양자화학 접근
세계의 분자 모델링 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
의약품 개발
신약 개발
기타 용도
세계의 분자 모델링 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
제약 및 생명공학기업
연구센터 및 학술기관
기타 최종 사용자
세계의 분자 모델링 시장 : 세분화 소프트웨어(유형별), 분석과 예측(2019-2024년, 2024-2029F, 2034F)
분자 시각화 소프트웨어
분자동역학 소프트웨어
양자화학 소프트웨어
도킹 소프트웨어
시뮬레이션 소프트웨어
기타 전문 소프트웨어
세계의 분자 모델링 시장 : 세분화 서비스(유형별), 분석과 예측(2019-2024년, 2024-2029F, 2034F)
컨설팅 서비스
커스텀 모델링 서비스
교육 및 지원 서비스
데이터 분석 서비스
클라우드 기반 서비스
제7장 지역별/국가별 분석
세계의 분자 모델링 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
세계의 분자 모델링 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
분자 모델링 시장 : 경쟁 구도
분자 모델링 시장 : 기업 프로파일
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
BioNTech SE : 개요, 제품 및 서비스, 전략 및 재무 분석
Dassault Systemes SE : 개요, 제품 및 서비스, 전략 및 재무 분석
Bruker Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Qiagen NV : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Physiomics plc
SilcsBio LLC
Compugen Ltd.
Certara Inc.
Schrodinger Inc.
Jubilant Biosys Ltd.
Simulations Plus Inc.
Genedata AG
Labvantage-Biomax GmbH
Acellera Ltd.
Advanced Chemistry Development Inc.
Molsoft LLC
Nimbus Therapeutics Inc.
Crown Bioscience Inc.
OTAVA Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
분자 모델링 시장(2029년) : 새로운 기회를 제공하는 국가
분자 모델링 시장(2029년) : 새로운 기회를 제공하는 부문
분자 모델링 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
CSM
영문 목차
영문목차
Molecular modeling involves the generation, representation, and/or manipulation of three-dimensional structures of chemical and biological molecules, along with determining physicochemical attributes. This process aids in understanding the Structural Activity Relationship (SAR) of biological molecules. Molecular modeling relies on computer programs and mathematical algorithms to predict and visualize the three-dimensional structure and properties of molecules.
The primary products of molecular modeling include software and services. Software encompasses a set of instructions, data, and programs that enable a computer or computing device to perform specific tasks, solve problems, or carry out operations. Molecular modeling employs approaches such as the molecular mechanics approach and quantum chemistry approach, particularly in applications such as drug development and drug discovery. End users of molecular modeling include pharmaceutical and biotechnology companies, research centers, academic institutions, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The molecular modeling market research report is one of a series of new reports from The Business Research Company that provides molecular modeling market statistics, including molecular modeling industry global market size, regional shares, competitors with a molecular modeling market share, detailed molecular modeling market segments, market trends and opportunities, and any further data you may need to thrive in the molecular modeling industry. This molecular modeling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The molecular modeling market size has grown rapidly in recent years. It will grow from $8.25 billion in 2024 to $9.44 billion in 2025 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to computational chemistry and molecular dynamics, early environmental and sustainability applications, enhanced visualization tools, increased use in enzyme and protein engineering, development of biomolecular modeling techniques.
The molecular modeling market size is expected to see rapid growth in the next few years. It will grow to $17.07 billion in 2029 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to integration of ai and machine learning algorithms, rise in drug discovery and development needs, expanding applications in material science, precision medicine and personalized treatment approaches, increasing utilization in virtual screening. Major trends in the forecast period include advancements in computational power, ai and machine learning integration, growth in drug discovery and development, expansion in material science applications, focus on predictive medicine.
The forecast of 16.0% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. drug discovery by inflating prices of quantum computing cloud platforms and Artificial intelligence(AI)-based protein folding software developed in France and Canada, resulting in delayed therapeutic development and higher computational biology expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The molecular modeling market is poised for growth, driven by the increasing momentum in drug development. Drug development encompasses the intricate process of discovering, designing, testing, and bringing new pharmaceutical compounds to market. Molecular modeling plays a pivotal role in this journey, aiding in understanding molecular interactions, assessing protein-ligand complex stability, ensuring functional reliability, and evaluating drug efficacy. A noteworthy surge in drug development is evident, with Accessibility Standards Canada reporting around 9,000 novel medications undergoing clinical trials in 2022, reflecting a substantial increase from the previous year's approximate count of 8,500 drugs. This surge in drug development activities is a key catalyst for the growth of the molecular modeling market.
The driving force for the molecular modeling market is the rise of personalized medicine. Personalized medicine tailors healthcare decisions and treatments based on an individual's unique genetic, molecular, and clinical characteristics. Molecular modeling is integral to this approach, facilitating the prediction of individual patient responses to treatments, the design of personalized drug therapies, and the optimization of treatment regimens based on molecular profiles. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), and approximately 34% of therapeutic NMEs, accounting for 12 of them, were classified as personalized medicines by the Personalized Medicine Coalition (PMC). The ascendancy of personalized medicine is a significant driver propelling the molecular modeling market forward.
The molecular modeling market faces a constraint due to the scarcity of experienced healthcare personnel. Adequate knowledge and expertise among healthcare professionals are essential for the effective interpretation and application of molecular modeling data in medical research and drug development. A significant shortage of essential healthcare workers has been reported, with projections indicating a worsening deficit of over 3.2 million workers within the next five years, as per a report by Mercer in September 2021. This shortage of experienced healthcare personnel poses a hindrance to the widespread adoption and utilization of molecular modeling techniques in the healthcare and pharmaceutical industries, thereby limiting the growth of the molecular modeling market.
Major companies in the molecular modeling market are at the forefront of innovation, introducing new technologies such as molecular modeling platforms. These platforms are comprehensive software suites offering tools for visualizing, simulating, and analyzing molecules. For instance, Cresset Group unveiled Flare V7 in August 2023, representing a cutting-edge drug design platform that seamlessly integrates ligand and structure-based approaches to enhance small-molecule discovery. It incorporates ensemble docking, Quantum Mechanics (QM) and Quantitative Structure-Activity Relationship (QSAR) methodologies, and various tools, marking a significant advancement in molecular modeling.
Major companies operating in the molecular modeling market report are Thermo Fisher Scientific Inc., BioNTech SE, Dassault Systemes SE, Bruker Corporation, Qiagen N.V., Physiomics PLC, SilcsBio LLC, Compugen Ltd., Certara Inc., Schrodinger Inc., Jubilant Biosys Ltd., Simulations Plus Inc., Genedata AG, Labvantage-Biomax GmbH, Acellera Ltd., Advanced Chemistry Development Inc., Molsoft L.L.C., Nimbus Therapeutics Inc., Crown Bioscience Inc., OTAVA Ltd., Chemical Computing Group, Molport SIA, Optibrium Ltd., BioSolveIT GmbH, Cyclica Inc., Cresset Group, Cyrus Biotechnology Inc., 3D Molecular Designs LLC, Inhibrx Inc., Leadscope Inc.
North America was the largest region in the molecular modeling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular modeling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the molecular modeling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The molecular modeling market consists of revenues earned by entities by providing services such as molecular modeling consultancy services, computational chemistry services, receptor-based and ligand-based virtual screening, and in silico screening and molecular modeling services. The market value includes the value of related goods sold by the service provider or included within the service offering. The molecular modeling market also includes sales of protein modeling and drug discovery tools, cheminformatics and computational chemistry databases, and visualization and molecular graphics tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Molecular Modeling Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on molecular modeling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for molecular modeling ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The molecular modeling market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Software; Services
2) By Approach: Molecular Mechanics Approach; Quantum Chemistry Approach
3) By Application: Drug Development; Drug Discovery; Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies; Research Centers And Academic Institutions; Other End Users
Subsegments:
1) By Software: Molecular Visualization Software; Molecular Dynamics Software; Quantum Chemistry Software; Docking Software; Simulation Software; Other Specialized Software
2) By Services: Consulting Services; Custom Modeling Services; Training And Support Services; Data Analysis Services; Cloud-Based Services
Companies Mentioned: Thermo Fisher Scientific Inc.; BioNTech SE; Dassault Systemes SE; Bruker Corporation; Qiagen N.V.; Physiomics plc; SilcsBio LLC; Compugen Ltd.; Certara Inc.; Schrodinger Inc.; Jubilant Biosys Ltd.; Simulations Plus Inc. ; Genedata AG ; Labvantage-Biomax GmbH; Acellera Ltd.; Advanced Chemistry Development Inc.; Molsoft L.L.C.; Nimbus Therapeutics Inc.; Crown Bioscience Inc.; OTAVA Ltd.; Chemical Computing Group; Molport SIA; Optibrium Ltd.; BioSolveIT GmbH; Cyclica Inc.; Cresset Group; Cyrus Biotechnology Inc.; 3D Molecular Designs LLC; Inhibrx Inc.; Leadscope Inc.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Molecular Modeling Market Characteristics
3. Molecular Modeling Market Trends And Strategies
4. Molecular Modeling Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Molecular Modeling Growth Analysis And Strategic Analysis Framework
5.1. Global Molecular Modeling PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Molecular Modeling Market Growth Rate Analysis
5.4. Global Molecular Modeling Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Molecular Modeling Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Molecular Modeling Total Addressable Market (TAM)
6. Molecular Modeling Market Segmentation
6.1. Global Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Software
Services
6.2. Global Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Molecular Mechanics Approach
Quantum Chemistry Approach
6.3. Global Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Development
Drug Discovery
Other Applications
6.4. Global Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Research Centers And Academic Institutions
Other End Users
6.5. Global Molecular Modeling Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Molecular Visualization Software
Molecular Dynamics Software
Quantum Chemistry Software
Docking Software
Simulation Software
Other Specialized Software
6.6. Global Molecular Modeling Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consulting Services
Custom Modeling Services
Training And Support Services
Data Analysis Services
Cloud-Based Services
7. Molecular Modeling Market Regional And Country Analysis
7.1. Global Molecular Modeling Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Molecular Modeling Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
